NICE rejects AstraZeneca’s breast cancer drug Faslodex
September 1, 2017Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical
NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …
NHS pumps £100m into GP recruitment as numbers plummet
September 1, 2017Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical
The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …
FDA approves treatment to counter CAR-T side-effects
August 31, 2017Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …
Has Trump’s power over pharma come to an end after Charlottesville?
August 31, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president
In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …
Lilly gets second shot at application for ‘blockbuster’ arthritis drug
August 31, 2017Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical
Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …
Teva scores expanded indication for Austedo in tardive dyskinesia
August 31, 2017Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals
Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …
CAR-T treatment is given ‘historic’ first approval by FDA
August 31, 2017Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …
J&J offers $134,000 grant to find the best start-up in South Korea
August 31, 2017Research and Development J&J. pharma, Johnson & Johnson, drugs, life sciences, medicine, pharmaceutical, south korea
Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …
Abbott issues patch for vulnerable heart devices
August 31, 2017Medical Communications, Sales and Marketing Abbot, St. Jude, biotech, drugs, pharma, pharmaceutical
A year on from the revelation that digital pacemakers were vulnerable to hackers, Abbott and the FDA has announced that …
EVP of Diabetes decamps from Sanofi to become Almirall CEO
August 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi’s Executive Vice President of Diabetes & Cardiocascular, Peter Guenter, has opted to end his 22-year-long stay at the company …
Immunotherapy firm develops breakthrough method for robust bispecific antibody production
August 30, 2017Research and Development antibodies, immunotherapy, merus, pharma, pharmaceuticals
A team of researchers at Dutch immunotherapy research firm Merus have developed an approach to efficiently manufacture bispecific antibodies which …
FDA approves first treatment for the ‘silent killer’
August 30, 2017Research and Development, Sales and Marketing Chagas disease, FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced that it has granted an accelerated approval for the use of benznidazole in children between the ages …
UK’s post-Brexit strategy looks to life sciences industry
August 30, 2017Medical Communications, Research and Development UK, biotech, brexit, drugs, life sciences, pharma, pharmaceutical
The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …
FDA fast-tracks recreational drug MDMA for treatment of PTSD
August 30, 2017Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals
In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …
The September 2017 issue of Pharmafocus is now live!
August 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, MSD, Pharmafocus, President trump, Takeda, Trump, charlottesville, life sciences, oncology, pharmaceuticals, phatma
The September edition of Pharmafocus is now available – click here to read online.
AstraZeneca unloads another drug for $400m
August 29, 2017Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical
AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …
Novartis names new Chief Digital Officer
August 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment
Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …
Thyroid disorders: An illness underestimated
August 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dr Bogumila Urgatz, Medical Director, Department Global Medical Affairs & General Medicine and Endocrinology, Merck KGaA discusses thryoid problems and …
New research reports first-ever response of central nervous tumour to CAR T therapy
August 29, 2017Manufacturing and Production, Research and Development CAR T, CAR-T, Cancer, life sciences, lymphoma, medicine, pharma, pharmaceuticals
Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …
Novartis’ drug prevents heart attacks and cancer but faces major challenges
August 29, 2017Manufacturing and Production, Research and Development Novartis, biotech, drugs, pharma, pharmaceutical
It would be expected that when a company releases data to show that its drug, previously only used in a …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
